Trial
NCT01607645
Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory AML and MDS
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Fred Hutchinson Cancer Center
Collaborators
National Cancer Institute (NCI)
Condition
Adult Acute Megakaryoblastic Leukemia (M7)
Intervention
decitabine
Why stopped
The study was terminated early because there were other competing protocols.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-03-31